Clarksville, TN Online: News, Opinion, Arts & Entertainment.


Topic: Blood Clots

American Stroke Association reports Rapid symptom improvement may not indicate better stroke recovery

 

American Stroke Association Meeting Report

American Stroke Association - American Heart AssociationLos Angeles, CA – Stroke patients whose symptoms quickly improved before hospital arrival did not always have better recoveries than other patients, according to research presented at the American Stroke Association’s International Stroke Conference 2016.

“Patients with very early rapid neurological improvement when first examined at the hospital still need to be considered for therapy to dissolve blood clots, given the high rate of unfavorable outcome,” said Clotilde Balucani, M.D., Ph.D., lead author and research assistant professor in neurology at The State University of New York Downstate Medical Center in Brooklyn.

Doctors may consider administering clot-busting therapy to those patients whose stroke symptoms rapidly improved before hospital arrival. (American Heart Association)

Doctors may consider administering clot-busting therapy to those patients whose stroke symptoms rapidly improved before hospital arrival. (American Heart Association)

«Read the rest of this article»

Sections: News | No Comments
 

American Heart Association says new reversible drug shows early promise in preventing dangerous Clots

 

American Heart Association Rapid Access Journal Report

American Heart AssociationDallas, TX – A new drug that protects against dangerous blood clots in patients undergoing procedures such as angioplasty to restore blood flow through the coronary arteries, appears safe, fast, and the effects are uniquely reversible, according to early testing described in the American Heart Association journal: Arteriosclerosis, Thrombosis and Vascular Biology.

Antiplatelet drugs currently available to patients carry an increased risk of bleeding.

A uniquely acting antiplatelet agent, PZ-128, appears to be safe and fast for preventing blood clots and its effects are reversible, reducing risk for excessive bleeding. (American Heart Association)

A uniquely acting antiplatelet agent, PZ-128, appears to be safe and fast for preventing blood clots and its effects are reversible, reducing risk for excessive bleeding. (American Heart Association)

«Read the rest of this article»

Sections: News | No Comments
 

American Heart Association says Clot-removal devices now recommended for some stroke patients

 

American Heart AssociationDallas, TX – For the first time, the American Heart Association/American Stroke Association recommends using a stent retrieval device to remove blood clots in select stroke patients who have clots obstructing the large arteries supplying blood to the brain, according to a new focused update published in the American Heart Association journal Stroke.

The optimal initial treatment for a clot-caused (ischemic) stroke remains intravenous delivery of the clot-busting medication tissue plasminogen activator (tPA).

FAST Stroke infographic. (American Heart Association) «Read the rest of this article»

Sections: News | No Comments
 


American Heart Association reports Women active a few times weekly have lower risk of Heart Disease, Stroke and Blood Clots

 

American Heart AssociationDallas, TX – Middle-aged women who are physically active a few times per week have lower risks of heart disease, stroke and blood clots than inactive women, according to research in the American Heart Association journal Circulation. Surprisingly, more frequent physical activity didn’t result in further reductions in risk, researchers said.

Physical activities associated with reduced risk included walking, gardening, and cycling.

Regular daily walking reduced the risk of stroke, regardless of the pace or distance. (American Heart Association)

Regular daily walking reduced the risk of stroke, regardless of the pace or distance. (American Heart Association)

«Read the rest of this article»

Sections: News | No Comments
 

American Heart Association says taking prescribed Anti-Clotting Drug may help save Sstent Patients’ Lives, but many are not filling Prescription

 

American Heart AssociationDallas, TX – If you’ve just received a coronary artery stent to prop open a blood vessel, your life may depend on filling your prescription and taking an anti-clotting drug within days of leaving the hospital, according to a large study in the Journal of the American Heart Association.

The risk of heart attack and death is highest within the first 30 days for those who delay taking their medication than during long-term follow-up out to two years.

Thirty percent of patients who had just received a stent failed to fill their prescription for an anti-clotting drug within three days of hospital discharge. (American Heart Association)

Thirty percent of patients who had just received a stent failed to fill their prescription for an anti-clotting drug within three days of hospital discharge. (American Heart Association)

«Read the rest of this article»

Sections: News | No Comments
 

American Heart Association reports “Off-the-shelf” artificial blood vessels may reduce dialysis complications

 

Artificial blood vessels remained durable in an animal trial and show promise for patients with end-stage kidney disease.

American Heart AssociationDallas, TX – “Off-the-shelf” blood vessels could one day reduce some complications of dialysis treatment, according to preliminary research presented at the American Heart Association’s Emerging Science Series Webinar.

Scientists bioengineered an artificial blood vessel by seeding human aorta cells onto a biodegradable mesh tube. In the process, a tubular vein develops in two months as the growing cells secrete proteins and the mesh support structure dissolves. The new vessel is then prepped in a way that minimizes chances of an immune reaction in the recipient. «Read the rest of this article»

Sections: News | No Comments
 

FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation

 

Washington, D.C.U.S. Food and Drug Administration - FDAThe U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Atrial fibrillation, one of the most common types of abnormal heart rhythm, is an abnormal, irregular, and rapid beating of the heart in which the heart’s two upper chambers (atria) do not contract properly, allowing blood clots to form in them. These clots can break off and travel to the brain or other parts of the body.  «Read the rest of this article»

Sections: News | No Comments
 


American Heart Association reports New evidence links ozone exposure to potential heart attacks

 

Young, healthy adults exposed to ozone for two hours developed changes in their cardiovascular system which could explain a possible link between ozone exposure and death.

American Heart AssociationDallas, TX – Young, healthy adult volunteers exposed for two hours to ozone developed physiological changes associated with cardiovascular ailments, according to a small study reported in Circulation, an American Heart Association journal.

Study participants showed evidence of vascular inflammation, a potential reduced ability to dissolve artery-blocking blood clots, and changes in the autonomic nervous system that controls the heart’s rhythm. The changes were temporary and reversible in these young, healthy participants. «Read the rest of this article»

Sections: News | No Comments
 

American Heart Association reports Biodegradable stent safe for long-term treatment of Coronary Artery Disease

 

American Heart AssociationDallas, TX – The first fully biodegradable coronary artery stent implanted in humans proved safe in a 10-year study published in Circulation, an American Heart Association journal.

Stents are mesh tubes inserted into coronary arteries to help prop them open and allow for blood flow to the heart muscle. «Read the rest of this article»

Sections: News | No Comments
 

Siblings of those with blood clots in leg have higher risk of same disorder

 

American Heart AssociationDallas, TX – Siblings of those who have been hospitalized with potentially lethal blood clots in the legs or pelvis are more likely to also suffer the disorder than those with healthy siblings, according to research published in Circulation: Journal of the American Heart Association.

The Swedish study is the first to show a direct correlation between venous thromboembolism (VTE) and family risk in a nationwide setting, sorted by age and gender.

VTE consists of deep vein thrombosis (DVT), which typically involves blood clots that form in the deep veins of the leg or pelvis, and its complication, pulmonary embolism (PE), a blood clot that travels to the lungs and lodges within the pulmonary arteries. «Read the rest of this article»

Sections: News | No Comments
 


Page 1 of 212

  • Visit Us On FacebookVisit Us On TwitterVisit Us On GooglePlusVisit Us On PinterestVisit Us On YoutubeCheck Our Feed
  • Personal Controls

    Archives